Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease-Reference-Cited by-同舟云学术

Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease

Published:2019-05 Issue:22 Volume:37 Page:2915-2924
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Da Silva Diane M.,Skeate Joseph G.,Chavez-Juan Elena,Lühen Kim P.,Wu Jiun-Ming,Wu Chia-Mao,Kast W. Martin,Hwang KinKai

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference52 articles.

1. Global burden of human papillomavirus and related diseases;Forman;Vaccine,2012

2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

3. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions;Serrano;Eur J Cancer,2015

4. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review;Kreimer;Cancer Epidemiol Biomarkers Prev,2005

5. The biology and life-cycle of human papillomaviruses;Doorbar;Vaccine,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses;International Journal of Biological Macromolecules;2024-06

2. A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer;Frontiers in Pharmacology;2024-05-10

3. Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions;MedComm;2023-09-14

4. Current Methods and Advances in the Immunotherapy Treatment of Non-Ovarian Gynaecological Cancers;Future Pharmacology;2023-06-01

5. Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors;Cancers;2023-03-29